Quantum Hi-Tech (China) Biological Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300149
  • 1d-1.29%
  • 1w-0.74%
  • 1m-5.15%
  • 1y-51.14%
ATH
  • ATH Price$27.28
  • ATH Date2015-06-11
  • % since ATH-80.43%
  • % to ATH410.95%
ATL
  • ATL Price$2.54
  • ATL Date2012-01-16
  • % from ATL110.05%
  • Last Low Price$3.98
  • Last Low Date2024-02-07
  • % From Last Low34.17%
IPO
  • IPO Price$47.77
  • % Current ROI USD-88.82%
  • ATH Price$27.28
  • % ROI ATH 107,327.90%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300149"]

Key Data [addtoany]

Current price $5.34
Sector Healthcare
Industry Biotechnology
Today's High/Low $5.48/$5.22
Volume 6,760,599.00
Previous Close $5.41
52 Week High/Low $10.94/$3.68
Market Cap 2,668,809,216.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$5.34
[addtoany]

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company provides medical contract research organization, and contract development and manufacturing organization services for pre-clinical stages.
It is also involved in the research, production, and sales of prebiotic fibers as a microecological fortification ingredient, ODM product, and food for special medical purposes product.
The company was formerly known as Quantum Hi-Tech (China) Biological Co., Ltd. and changed its name to Quantum Hi-Tech (China) Biological Co., Ltd. in September 2020. Quantum Hi-Tech (China) Biological Co., Ltd. was founded in 2000 and is headquartered in Guangzhou, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity